Evaluation of chemosensitivity prediction using quantitative dose–response curve classification for highly advanced/relapsed gastric cancer

Table 1 Patient characteristics

Characteristic	Total (number = 43)		Ascites (number = 22)		Solid tumor (number = 21)
	Number	%	Number	%	Number	%
Age, years
Median	59		53		68
Range	22 to 85		22 to 78		30 to 85
Sex
Male	30	69.8	15	68.2	15	71.4
Female	13	30.2	7	31.8	6	28.6
Stage ^{a, b}
II	2	4.7	0	0	2	9.5
IIIA	1	2.3	0	0	1	4.8
IIIB	5	11.6	1	4.5	4	19.0
IV	35	81.4	21	95.5	14	66.7
Histology^b
Intestinal	10	23.3	5	22.7	5	23.8
Diffuse	33	76.7	17	77.3	16	76.2
Stroma^b
Medullary type	5	11.6	0	0	5	23.8
Intermediate type	9	20.9	3	13.6	6	28.6
Scirrhous type	12	27.9	6	27.3	6	28.6
Unknown	17	39.5	13	59.1	4	19.0
Pre-therapy
Performed	30	69.8	16	72.7	14	66.7
Not performed	13	30.2	6	27.3	7	33.3

^aAJCC (American Joint Commettee on Cancer)/UICC (Union for International Cancer Control) classification.
^bStages, Histology, and Stroma for Ascites are of the primary lesions.

ISSN: 1477-7819